Treatment for hot flushes in women receiving tamoxifen.
Bydder
Sean A
SA
Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA . s_bydder@hotmail.com
Spry
Nigel A
NA
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003511:Cyclohexanols / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D019584:Hot Flashes / Q000188:drug therapy*; D006801:Humans; D019290:Megestrol Acetate / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D013629:Tamoxifen / Q000627:therapeutic use; D000069470:Venlafaxine Hydrochloride
D018931:Antineoplastic Agents, Hormonal; D003511:Cyclohexanols; D019290:Megestrol Acetate; D017367:Selective Serotonin Reuptake Inhibitors; D013629:Tamoxifen; D000069470:Venlafaxine Hydrochloride